175 related articles for article (PubMed ID: 6482087)
1. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on 6-amidino-2-naphthyl[4-(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethane sulfonate (FUT-187). I: Inhibitory activities on various kinds of enzymes in vitro and anticomplement activity in vivo.
Oda M; Ino Y; Nakamura K; Kuramoto S; Shimamura K; Iwaki M; Fujii S
Jpn J Pharmacol; 1990 Jan; 52(1):23-34. PubMed ID: 1689782
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor.
Hitomi Y; Fujii S
Int Arch Allergy Appl Immunol; 1982; 69(3):262-7. PubMed ID: 6215361
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate.
Nakayama T; Taira S; Ikeda M; Ashizawa H; Oda M; Arakawa K; Fujii S
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):117-25. PubMed ID: 8448813
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological studies of FUT-175, nafamstat mesilate. III. Anti-inflammatory activities of FUT-175].
Iwaki M; Oda M; Ozeki M; Ino Y; Suzuki K; Koshiyama Y; Motoyoshi A; Ogihara M; Suzuki S; Fujita M
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):373-84. PubMed ID: 6239813
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro].
Nakamura K; Johmura A; Oda M; Ino Y; Uchiyama H; Ohtani H; Miyazaki H; Kurumi M; Akizawa Y; Oka T
Yakugaku Zasshi; 1995 Mar; 115(3):201-12. PubMed ID: 7738778
[TBL] [Abstract][Full Text] [Related]
7. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
Fujii S; Hitomi Y
Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of newly synthesized active center-directed trypsin-like serine protease inhibitors on the complement system.
Ueda N; Midorikawa A; Ino Y; Oda M; Nakamura K; Suzuki S; Kurumi M
Inflamm Res; 2000 Jan; 49(1):42-6. PubMed ID: 10778920
[TBL] [Abstract][Full Text] [Related]
9. The effect of FUT-175 (Nafamstat Mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo.
Issekutz AC; Roland DM; Patrick RA
Int J Immunopharmacol; 1990; 12(1):1-9. PubMed ID: 2303313
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of a novel synthetic protease inhibitor, FUT-175, on the paw edema in rats and zymosan-induced complement activation in vitro.
Sato T; Ino Y; Koshiyama Y; Motoyoshi A; Oda M; Iwaki M
Jpn J Pharmacol; 1986 Dec; 42(4):587-9. PubMed ID: 3807057
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.
Hitomi Y; Ikari N; Fujii S
Haemostasis; 1985; 15(3):164-8. PubMed ID: 3161808
[TBL] [Abstract][Full Text] [Related]
12. New synthetic inhibitor to the alternative complement pathway.
Ikari N; Sakai Y; Hitomi Y; Fujii S
Immunology; 1983 Aug; 49(4):685-91. PubMed ID: 6553561
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of FUT-175, a new synthetic protease inhibitor, on intravascular hemolysis by human serum in mice.
Ino Y; Sato T; Suzuki S; Iwaki M; Yoshikawa T
Int J Immunopharmacol; 1987; 9(5):533-7. PubMed ID: 3623771
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor nafamostat mesilate attenuates complement activation and improves function of xenografts in a discordant lung perfusion model.
Tagawa T
Xenotransplantation; 2011; 18(6):315-9. PubMed ID: 22168138
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
Ino Y; Suzuki K; Sato T; Iwaki M
Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.
Fujita Y; Inoue I; Inagi R; Miyata T; Shinzato T; Sugiyama S; Miyama A; Maeda K
Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):393-7. PubMed ID: 8341019
[TBL] [Abstract][Full Text] [Related]
18. Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation.
Ino Y; Sato T; Koshiyama Y; Suzuki K; Oda M; Iwaki M
Gen Pharmacol; 1987; 18(5):513-6. PubMed ID: 3308629
[TBL] [Abstract][Full Text] [Related]
19. [Immunopharmacological actions of 6-amidino-2-naphthyl-4-guanidinobenzoate (FUT-175). 1. Effect of FUT-175 on immune response and host defense in mice].
Yanagihara Y; Shida T
Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):565-72. PubMed ID: 6618346
[TBL] [Abstract][Full Text] [Related]
20. [The effect of the protease inhibitor FUT-175 on phospholipase A2, complement, prostaglandins and prekallikrein during endotoxin shock].
Okuda Y; Ogata H
Masui; 1989 Mar; 38(3):334-42. PubMed ID: 2739065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
